Skip to main content
. 2023 Jun 12;16:2405–2417. doi: 10.2147/IJGM.S407725

Figure 1.

Figure 1

TIGIT expression in pan-cancer tissues and Kaplan-Meier survival curves of BC patients. (A) TIGIT level in pan-cancer tissues and normal tissues. (B) TIGIT expression in invasive BC tumor tissue (TT) versus adjacent normal tissue (NT). (C) Relationship between TIGIT expression and BC stage. (D and E) Recurrence-free survival (RFS) and overall survival (OS) of BC patients with high-level TIGIT versus low-level TIGIT, respectively.